Posted by Michael Wonder on 06 Aug 2022
US Government about to get long awaited powers on drug pricing
6 August 2022 - Pharma rarely loses in Washington. For years, the industry has successfully defeated US Government efforts to rein in drug pricing, arguing any such moves would prevent companies from developing newer and better medicines.
That argument doesn’t seem to be enough anymore.
